Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Change in Cash (2022 - 2025)

Bioregenx's Change in Cash history spans 4 years, with the latest figure at $22436.0 for Q4 2025.

  • Quarterly results put Change in Cash at $22436.0 for Q4 2025, up 292.14% from a year ago — trailing twelve months through Dec 2025 was $10979.0 (up 116.39% YoY), and the annual figure for FY2025 was $10979.0, up 116.39%.
  • Change in Cash for Q4 2025 was $22436.0 at Bioregenx, up from $491.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $67439.0 in Q4 2023 to a low of -$224118.0 in Q2 2023.
  • The 4-year median for Change in Cash is -$6279.5 (2022), against an average of -$35687.2.
  • Peak annual rise in Change in Cash hit 7896.42% in 2023, while the deepest fall reached 28655.33% in 2023.
  • Year by year, Change in Cash stood at -$865.0 in 2022, then skyrocketed by 7896.42% to $67439.0 in 2023, then crashed by 117.31% to -$11677.0 in 2024, then soared by 292.14% to $22436.0 in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at $22436.0, $491.0, and -$37169.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.